BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12065621)

  • 1. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats.
    Hashimoto M; Hossain S; Shimada T; Sugioka K; Yamasaki H; Fujii Y; Ishibashi Y; Oka J; Shido O
    J Neurochem; 2002 Jun; 81(5):1084-91. PubMed ID: 12065621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of prescription n-3 fatty acids against impairment of spatial cognitive learning ability in amyloid β-infused rats.
    Hashimoto M; Tozawa R; Katakura M; Shahdat H; Haque AM; Tanabe Y; Gamoh S; Shido O
    Food Funct; 2011 Jul; 2(7):386-94. PubMed ID: 21894325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats.
    Hashimoto M; Tanabe Y; Fujii Y; Kikuta T; Shibata H; Shido O
    J Nutr; 2005 Mar; 135(3):549-55. PubMed ID: 15735092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions.
    Hashimoto M; Hossain S; Agdul H; Shido O
    Biochim Biophys Acta; 2005 Dec; 1738(1-3):91-8. PubMed ID: 16427803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat by repressing amyloid beta accumulation.
    Lee CL; Kuo TF; Wang JJ; Pan TM
    J Neurosci Res; 2007 Nov; 85(14):3171-82. PubMed ID: 17663476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
    J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer's disease.
    Bagheri M; Joghataei MT; Mohseni S; Roghani M
    Neurobiol Learn Mem; 2011 Mar; 95(3):270-6. PubMed ID: 21144907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid-induced protective effect against impaired learning in amyloid beta-infused rats is associated with increased synaptosomal membrane fluidity.
    Hashimoto M; Hossain S; Shimada T; Shido O
    Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):934-9. PubMed ID: 17002670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea catechins prevent cognitive deficits caused by Abeta1-40 in rats.
    Haque AM; Hashimoto M; Katakura M; Hara Y; Shido O
    J Nutr Biochem; 2008 Sep; 19(9):619-26. PubMed ID: 18280729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
    Sharma S; Verma S; Kapoor M; Saini A; Nehru B
    Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease.
    Wang X; Hu X; Yang Y; Takata T; Sakurai T
    Exp Neurol; 2015 Sep; 271():145-54. PubMed ID: 26057947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of Aβ1-42 to lipid rafts of RBC is enhanced by dietary docosahexaenoic acid in rats: Implicates to Alzheimer's disease.
    Hashimoto M; Hossain S; Katakura M; Al Mamun A; Shido O
    Biochim Biophys Acta; 2015 Jun; 1848(6):1402-9. PubMed ID: 25782726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary arachidonic acid increases deleterious effects of amyloid-β oligomers on learning abilities and expression of AMPA receptors: putative role of the ACSL4-cPLA
    Thomas MH; Paris C; Magnien M; Colin J; Pelleïeux S; Coste F; Escanyé MC; Pillot T; Olivier JL
    Alzheimers Res Ther; 2017 Aug; 9(1):69. PubMed ID: 28851448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease.
    Hashimoto M; Hossain S
    J Pharmacol Sci; 2011; 116(2):150-62. PubMed ID: 21606627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease.
    Rahman SO; Panda BP; Parvez S; Kaundal M; Hussain S; Akhtar M; Najmi AK
    Biomed Pharmacother; 2019 Feb; 110():47-58. PubMed ID: 30463045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein(42) and up-regulates cytoskeletal protein expression.
    Wang PY; Chen JJ; Su HM
    J Nutr Biochem; 2010 Apr; 21(4):345-50. PubMed ID: 19423322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease.
    Esmaeili Tazangi P; Moosavi SM; Shabani M; Haghani M
    Pharmacol Biochem Behav; 2015 Mar; 130():15-21. PubMed ID: 25553822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhizophora mucronata attenuates beta-amyloid induced cognitive dysfunction, oxidative stress and cholinergic deficit in Alzheimer's disease animal model.
    Suganthy N; Malar DS; Devi KP
    Metab Brain Dis; 2016 Aug; 31(4):937-49. PubMed ID: 27188290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats.
    Baraka A; ElGhotny S
    Eur J Pharmacol; 2010 Sep; 641(2-3):123-7. PubMed ID: 20639139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harpagoside ameliorates the amyloid-β-induced cognitive impairment in rats via up-regulating BDNF expression and MAPK/PI3K pathways.
    Li J; Ding X; Zhang R; Jiang W; Sun X; Xia Z; Wang X; Wu E; Zhang Y; Hu Y
    Neuroscience; 2015 Sep; 303():103-14. PubMed ID: 26135675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.